The DOI matches its Crossref record; 65 of the 65 references it cites were found in a registry or an index.
Early mortality among adults accessing antiretroviral treatment programmes in sub-Saharan Africa
Open accessAbstract
Two-thirds of the world's HIV-infected people live in sub-Saharan Africa, and more than 1.5 million of them die annually. As access to antiretroviral treatment has expanded within the region; early pessimism concerning the delivery of antiretroviral treatment using a large-scale public health approach has, at least in the short term, proved to be broadly unfounded. Immunological and virological responses to ART are similar to responses in patients treated in high-income countries. Despite this, however, early mortality rates in sub-Saharan Africa are very high; between 8 and 26% of patients die in the first year of antiretroviral treatment, with most deaths occurring in the first few months. Patients typically access antiretroviral treatment with advanced symptomatic disease, and mortality is strongly associated with baseline CD4 cell count less than 50 cells/mul and WHO stage 4 disease (AIDS). Although data are limited, leading causes of death appear to be tuberculosis, acute sepsis, cryptococcal meningitis, malignancy and wasting syndrome. Mortality rates are likely to depend not only on the care delivered by antiretroviral treatment programmes, but more fundamentally on how advanced disease is at programme enrollment and the quality of preceding healthcare. In addition to improving delivery of antiretroviral treatment and providing it free of charge to the patient, strategies to reduce mortality must include earlier diagnosis of HIV infection, strengthening of longitudinal HIV care and timely initiation of antiretroviral treatment. Health systems delays in antiretroviral treatment initiation must be minimized, especially in patients who present with advanced immunodeficiency.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Meta-analysis in clinical trials
DerSimonian, R., & Laird, N. (1986) · Controlled Clinical Trials · doi:10.1016/0197-2456(86)90046-2 · Cited by 39,552
Palella, F. J., Delaney, K. M., Moorman, A. C., Loveless, M. O., Fuhrer, J., Satten, G. A., Aschman, D. J., & Holmberg, S. D. (1998) · New England Journal of Medicine · doi:10.1056/nejm199803263381301 · Cited by 9,405
Egger, M., May, M., Chêne, G., Phillips, A. N., Ledergerber, B., Dabis, F., Costagliola, D., Monforte, A. D., de Wolf, F., Reiss, P., et al. (2002) · The Lancet · doi:10.1016/s0140-6736(02)09411-4 · Cited by 1,525
Decline in the AIDS and death rates in the EuroSIDA study: an observational study
Mocroft, A., Ledergerber, B., Katlama, C., Kirk, O., Reiss, P., Monforte, A. D., Knysz, B., Dietrich, M., Phillips, A., & Lundgren, J. (2003) · The Lancet · doi:10.1016/s0140-6736(03)13802-0 · Cited by 1,241
Patient Retention in Antiretroviral Therapy Programs in Sub-Saharan Africa: A Systematic Review
Rosen, S., Fox, M. P., & Gill, C. J. (2007) · PLoS Medicine · doi:10.1371/journal.pmed.0040298 · Cited by 796
Stringer, J. S. A., Zulu, I., Levy, J., Stringer, E. M., Mwango, A., Chi, B. H., Mtonga, V., Reid, S., Cantrell, R. A., Bulterys, M., et al. (2006) · JAMA · doi:10.1001/jama.296.7.782 · Cited by 655
Outcomes after two years of providing antiretroviral treatment in Khayelitsha, South Africa
Coetzee, D., Hildebrand, K., Boulle, A., Maartens, G., Louis, F., Labatala, V., Reuter, H., Ntwana, N., & Goemaere, E. (2004) · AIDS · doi:10.1097/00002030-200404090-00006 · Cited by 584
The mortality and pathology of HIV infection in a West African city
Lucas, S. B., Hounnou, A., Peacock, C., Beaumel, A., Djomand, G., NʼGbichi, J.-M., Yeboue, K., Hondé, M., Diomande, M., Giordano, C., et al. (1993) · AIDS · doi:10.1097/00002030-199312000-00005 · Cited by 562
Lawn, S. D., Bekker, L.-G., & Miller, R. F. (2005) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(05)70140-7 · Cited by 545
Self-citationFerradini, L., Jeannin, A., Pinoges, L., Izopet, J., Odhiambo, D., Mankhambo, L., Karungi, G., Szumilin, E., Balandine, S., Fedida, G., et al. (2006) · The Lancet · doi:10.1016/s0140-6736(06)68580-2 · Cited by 450
Kaufmann, G. R. (2003) · Archives of Internal Medicine · doi:10.1001/archinte.163.18.2187 · Cited by 409
Lawn, S. D., Myer, L., Bekker, L.-G., & Wood, R. (2006) · AIDS · doi:10.1097/01.aids.0000238406.93249.cd · Cited by 363
Self-citationLawn, S. D., Myer, L., Orrell, C., Bekker, L.-G., & Wood, R. (2005) · AIDS · doi:10.1097/01.aids.0000194802.89540.e1 · Cited by 359
Self-citationTreatment of tuberculosis in HIV-infected persons in the era of highly active antiretroviral therapy
Dean, G. L., Edwards, S. G., Ives, N. J., Matthews, G., Fox, E. F., Navaratne, L., Fisher, M., Taylor, G. P., Miller, R., Taylor, C. B., et al. (2002) · AIDS · doi:10.1097/00002030-200201040-00010 · Cited by 354
Lawn, S. D., Myer, L., Bekker, L.-G., & Wood, R. (2007) · AIDS · doi:10.1097/qad.0b013e328011efac · Cited by 343
Self-citationAdherence is not a barrier to successful antiretroviral therapy in South Africa
Orrell, C., Bangsberg, D. R., Badri, M., & Wood, R. (2003) · AIDS · doi:10.1097/00002030-200306130-00011 · Cited by 341
Self-citationLortholary, O., Fontanet, A., Mémain, N., Martin, A., Sitbon, K., & Dromer, F. (2005) · AIDS · doi:10.1097/01.aids.0000174450.70874.30 · Cited by 324
Weidle, P. J., Malamba, S., Mwebaze, R., Sozi, C., Rukundo, G., Downing, R., Hanson, D., Ochola, D., Mugyenyi, P., Mermin, J., et al. (2002) · The Lancet · doi:10.1016/s0140-6736(02)09330-3 · Cited by 315
Ivers, L. C., Kendrick, D., & Doucette, K. (2005) · Clinical Infectious Diseases · doi:10.1086/431199 · Cited by 312
Zachariah, R., Fitzgerald, M., Massaquoi, M., Pasulani, O., Arnould, L., Makombe, S., & Harries, A. D. (2006) · AIDS · doi:10.1097/qad.0b013e32801086b0 · Cited by 284
Self-citationEtard, J.-F., Ndiaye, I., Thierry-Mieg, M., Guèye, N. F. N., Guèye, P. M., Lanièce, I., Dieng, A. B., Diouf, A., Laurent, C., Mboup, S., et al. (2006) · AIDS · doi:10.1097/01.aids.0000226959.87471.01 · Cited by 278
Cost-Effectiveness of HIV Treatment in Resource-Poor Settings — The Case of Côte d'Ivoire
Goldie, S. J., Yazdanpanah, Y., Losina, E., Weinstein, M. C., Anglaret, X., Walensky, R. P., Hsu, H. E., Kimmel, A., Holmes, C., Kaplan, J. E., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmsa060247 · Cited by 272
Self-citationBicanic, T., Meintjes, G., Wood, R., Hayes, M., Rebe, K., Bekker, L.-G., & Harrison, T. (2007) · Clinical Infectious Diseases · doi:10.1086/518607 · Cited by 271
Self-citationNachega, J. B., Hislop, M., Dowdy, D. W., Lo, M., Omer, S. B., Regensberg, L., Chaisson, R. E., & Maartens, G. (2006) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/01.qai.0000225015.43266.46 · Cited by 270
Severe Hepatotoxicity Associated with Nevirapine Use in HIV‐Infected Subjects
Sanne, I., Mommeja‐Marin, H., Hinkle, J., Bartlett, J. A., Lederman, M. M., Maartens, G., Wakeford, C., Shaw, A., Quinn, J., Gish, R. G., et al. (2005) · The Journal of Infectious Diseases · doi:10.1086/428093 · Cited by 242
Wood, R., Middelkoop, K., Myer, L., Grant, A. D., Whitelaw, A., Lawn, S. D., Kaplan, G., Huebner, R., McIntyre, J., & Bekker, L.-G. (2007) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200606-759oc · Cited by 239
Self-citationTrue outcomes for patients on antiretroviral therapy who are lost to follow-up in Malawi
Kwong-Leung Yu, J. (2007) · Bulletin of the World Health Organization · doi:10.2471/blt.06.037739 · Cited by 234
Lawn, S. D., Myer, L., Harling, G., Orrell, C., Bekker, L.-G., & Wood, R. (2006) · Clinical Infectious Diseases · doi:10.1086/507095 · Cited by 226
Self-citationBicanic, T., Harrison, T., Niepieklo, A., Dyakopu, N., & Meintjes, G. (2006) · Clinical Infectious Diseases · doi:10.1086/507895 · Cited by 224
Danel, C., Moh, R., Minga, A., Anzian, A., Ba-Gomis, O., Kanga, C., Nzunetu, G., Gabillard, D., Rouet, F., Sorho, S., et al. (2006) · The Lancet · doi:10.1016/s0140-6736(06)68887-9 · Cited by 221
Self-citationMoore, D., Liechty, C., Ekwaru, P., Were, W., Mwima, G., Solberg, P., Rutherford, G., & Mermin, J. (2007) · AIDS · doi:10.1097/qad.0b013e328013f632 · Cited by 217
Mermin, J., Ekwaru, J. P., Liechty, C. A., Were, W., Downing, R., Ransom, R., Weidle, P., Lule, J., Coutinho, A., & Solberg, P. (2006) · The Lancet · doi:10.1016/s0140-6736(06)68541-3 · Cited by 212
Liechty, C. A., Solberg, P., Were, W., Ekwaru, J. P., Ransom, R. L., Weidle, P. J., Downing, R., Coutinho, A., & Mermin, J. (2007) · Tropical Medicine & International Health · doi:10.1111/j.1365-3156.2007.01874.x · Cited by 207
No room for complacency about adherence to antiretroviral therapy in sub-Saharan Africa
Gill, C. J., Hamer, D. H., Simon, J. L., Thea, D. M., & Sabin, L. L. (2005) · AIDS · doi:10.1097/01.aids.0000180094.04652.3b · Cited by 196
Outcome of HIV‐Associated Tuberculosis in the Era of Highly Active Antiretroviral Therapy
Dheda, K., Lampe, F. C., Johnson, M. A., & Lipman, M. C. (2004) · The Journal of Infectious Diseases · doi:10.1086/424676 · Cited by 195
Mtei, L., Matee, M., Herfort, O., Bakari, M., Horsburgh, C. R., Waddell, R., Cole, B. F., Vuola, J. M., Tvaroha, S., Kreiswirth, B., et al. (2005) · Clinical Infectious Diseases · doi:10.1086/429825 · Cited by 189
Toure, S., Kouadio, B., Seyler, C., Traore, M., Dakoury-Dogbo, N., Duvignac, J., Diakite, N., Karcher, S., Grundmann, C., Marlink, R., et al. (2008) · AIDS · doi:10.1097/qad.0b013e3282f768f8 · Cited by 185
Self-citationJenny‐Avital, E. R., & Abadi, M. (2002) · Clinical Infectious Diseases · doi:10.1086/344467 · Cited by 185
Fairall, L. R. (2008) · Archives of Internal Medicine · doi:10.1001/archinternmed.2007.10 · Cited by 173
Hoffmann, C. J., Charalambous, S., Thio, C. L., Martin, D. J., Pemba, L., Fielding, K. L., Churchyard, G. J., Chaisson, R. E., & Grant, A. D. (2007) · AIDS · doi:10.1097/qad.0b013e32814e6b08 · Cited by 172
Long-Term Benefits of Highly Active Antiretroviral Therapy in Senegalese HIV-1-Infected Adults
Laurent, C., Ngom Gueye, N. F., Ndour, C. T., Gueye, P. M., Diouf, M., Diakhat??, N., Tour?? Kane, N. C., Lani??ce, I., Ndir, A., Vergne, L., et al. (2005) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/00126334-200501010-00003 · Cited by 160
Bekker, L., Myer, L., Orrell, C., Lawn, S. D., & Wood, R. (2006) · PubMed · doi:10.7196/samj.1072 · Cited by 158
Self-citationMoh, R., Danel, C., Messou, E., Ouassa, T., Gabillard, D., Anzian, A., Abo, Y., Salamon, R., Bissagnené, E., Seyler, C., et al. (2007) · AIDS · doi:10.1097/qad.0b013e3282f09876 · Cited by 156
Self-citationManosuthi, W., Kiertiburanakul, S., Phoorisri, T., & D, S. S. M. (2006) · Journal of Infection · doi:10.1016/j.jinf.2006.01.002 · Cited by 148
Cost-Effectiveness of Highly Active Antiretroviral Therapy in South Africa
Badri, M., Maartens, G., Mandalia, S., Bekker, L., Penrod, J. R., Platt, R. W., Wood, R., & Beck, E. J. (2005) · PLoS Medicine · doi:10.1371/journal.pmed.0030004 · Cited by 143
Self-citationDjomand, G., Roels, T. H., Ellerbrock, T. V., Hanson, D. L., Diomandé, F. V. K., Monga, B., Maurice, C., Nkengasong, J. N., Konan-Koko, R., Kadio, A., et al. (2003) · AIDS · doi:10.1097/00002030-200317003-00002 · Cited by 143
Boulle, A., Orrell, C., Kaplan, R., Cutsem, G. V., McNally, M., Hilderbrand, K., Myer, L., Egger, M., Coetzee, D. J., Maartens, G., et al. (2007) · Antiviral Therapy · doi:10.1177/135965350701200508 · Cited by 139
Self-citationLawn, S. D., Myer, L., Bekker, L., & Wood, R. (2006) · BMC Infectious Diseases · doi:10.1186/1471-2334-6-59 · Cited by 134
Self-citationLawn, S. D., Bekker, L., Myer, L., Orrell, C., & Wood, R. (2005) · AIDS · doi:10.1097/01.aids.0000191232.16111.f9 · Cited by 130
Self-citationScaling up antiretroviral treatment in resource-poor settings
Harries, A. D., Schouten, E. J., & Libamba, E. (2006) · The Lancet · doi:10.1016/s0140-6736(06)68809-0 · Cited by 130
Self-citationMoh, R., Danel, C., Sorho, S., Sauvageot, D., Anzian, A., Minga, A. K., Ba-Gomis, O., Kanga, C., Inwoley, A., Gabillard, D., et al. (2005) · Antiviral Therapy · doi:10.1177/135965350501000510 · Cited by 120
Self-citationBadri, M., Lawn, S. D., & Wood, R. (2006) · The Lancet · doi:10.1016/s0140-6736(06)69117-4 · Cited by 120
Self-citationBadri, M., Cleary, S., Maartens, G., Pitt, J., Bekker, L., Orrell, C., & Wood, R. (2006) · Antiviral Therapy · doi:10.1177/135965350601100103 · Cited by 103
Self-citationInitiating highly active antiretroviral therapy in sub-Saharan Africa
Badri, M., Bekker, L., Orrell, C., et al. (2004) · AIDS · doi:10.1097/00002030-200405210-00009 · Cited by 85
Tuberculosis Preventive Therapy in the Era of HIV Infection: Overview and Research Priorities
Churchyard, G., Scano, F., Grant, A. D., & Chaisson, R. E. (2007) · The Journal of Infectious Diseases · doi:10.1086/518662 · Cited by 83
Anglaret, X., Messou, E., Ouassa, T., Touré, S., Dakoury-Dogbo, N., Combe, P., Mahassadi, A. K., Seyler, C., N’Dri-Yoman, T., & Salamon, R. (2003) · AIDS · doi:10.1097/00002030-200303070-00013 · Cited by 78
Self-citationvan Oosterhout, J. J. G., Laufer, M. K., Graham, S. M., Thumba, F., Perez, M. A., Chimbiya, N., Wilson, L., Chagomerana, M., Molyneux, M. E., Zijlstra, E. E., et al. (2005) · PubMed · Cited by 68
Lowrance, D. W., Makombe, S. D., Harries, A. D., Yu, J. K., Aberle-Grasse, J. M., Eiger, O., Shiraishi, R. W., Marston, B. J., Ellerbrock, T. V., & Libamba, E. (2007) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0b013e3181378ed2 · Cited by 66
Self-citationDanel, C., Moh, R., Anzian, A., Abo, Y., Chenal, H., Guéhi, C., Gabillard, D., Sorho, S., Rouet, F., Eholié, S. P., et al. (2006) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/01.qai.0000219777.04927.50 · Cited by 55
Self-citationBlanc, F. –., Havlir, D. V., Onyebujoh, P., Thim, S., Goldfeld, A. E., & Delfraissy, J. (2007) · The Journal of Infectious Diseases · doi:10.1086/518658 · Cited by 53
Baseline Predictors of CD4 T-Lymphocyte Recovery With Combination Antiretroviral Therapy
Bennett, K. K., DeGruttola, V. G., Marschner, I. C., Havlir, D. V., & Richman, D. D. (2002) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/00126334-200209010-00003 · Cited by 29
Lawn, S. D., & Wood, R. (2007) · PubMed · Cited by 21
Self-citationOptimum Time to Initiate Antiretroviral Therapy in Patients With HIV-Associated Tuberculosis
Lawn, S. D., & Wood, R. (2007) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0b013e3181398d28 · Cited by 17
Self-citation
Cited by
Global burden of disease of HIV-associated cryptococcal meningitis: an updated analysis
Rajasingham, R., Smith, R. M., Park, B. J., Jarvis, J. N., Govender, N. P., Chiller, T. M., Denning, D. W., Loyse, A., & Boulware, D. R. (2017) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(17)30243-8 · Cited by 1,861
Fox, M. P., & Rosen, S. (2010) · Tropical Medicine & International Health · doi:10.1111/j.1365-3156.2010.02508.x · Cited by 559
Karim, S. S. A., Churchyard, G. J., Karim, Q. A., & Lawn, S. D. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60916-8 · Cited by 545
Self-citationTiming of Antiretroviral Therapy after Diagnosis of Cryptococcal Meningitis
Boulware, D. R., Meya, D. B., Muzoora, C., Rolfes, M. A., Huppler Hullsiek, K., Musubire, A., Taseera, K., Nabeta, H. W., Schutz, C., Williams, D. A., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1312884 · Cited by 497
Govindasamy, D., Ford, N., & Kranzer, K. (2012) · AIDS · doi:10.1097/qad.0b013e3283578b9b · Cited by 435
Metadata
- Authors
- Lawn, S. D., Harries, A. D., Anglaret, X., Myer, L., & Wood, R.
- Venue
- AIDS
- Published
- 2008-10-01
- Volume
- 22
- Issue
- 15
- Pages
- 1897-1908
- ISSN
- 0269-9370 (ISSN-L)
- OpenAlex
- W1999408007
- Cited by
- 639
- References
- 65
- FWCI
- 41.72
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.